Related Experiment Video
Updated: Nov 2, 2025
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
563
Helicobacter Pylori Eradication Therapy: Still a Challenge
Muhammad Hafeez1, Zafar A Qureshi1, Abdul L Khattak2
1Gastroenterology, Pak Emirates Military Hospital, Rawalpindi, PAK.
Cureus
|June 11, 2021
Summary
Patient compliance with Helicobacter pylori (H. pylori) eradication therapy is crucial. Regimens with fewer adverse effects, such as levofloxacin-based triple, concomitant, and standard triple therapy with probiotics, demonstrate higher patient tolerance and acceptance.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Background:
- Helicobacter pylori (H. pylori) infection is a global health concern.
- Adverse effects of H. pylori therapies often lead to poor patient compliance.
- Optimizing eradication regimens is essential for treatment success.
Purpose of the Study:
- To evaluate the association between patient compliance and adverse effects of H. pylori eradication therapy.
- To compare the tolerability of various H. pylori eradication drug regimens.
- To identify H. pylori treatment strategies with improved patient acceptance.
Main Methods:
- An observational study involving 250 patients with dyspeptic symptoms was conducted.
- Patients received one of nine H. pylori eradication regimens for two weeks.
- Compliance and adverse effects were assessed through patient interviews post-treatment.
Main Results:
- 80.4% of patients completed their H. pylori treatment regimen.
- 19.6% discontinued treatment due to adverse effects (p<0.005).
- Levofloxacin-based triple, concomitant, and standard triple therapy with probiotics showed the highest tolerance (≥85%). Common side effects included abdominal pain, taste alteration, and diarrhea.
Conclusions:
- Patient compliance in H. pylori eradication therapy is significantly influenced by the occurrence of adverse effects.
- Levofloxacin-based triple, concomitant, and standard triple regimens with probiotics are well-tolerated and maximally acceptable H. pylori treatments.
- Minimizing adverse effects is key to improving patient adherence and treatment outcomes for H. pylori infections.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
681
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
681
01:26Peptic Ulcer Disease IV: Management
203
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
203
01:23Gastritis III: Clinical Manifestations and Management
665
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
665
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
275
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
275
01:30Peptic Ulcer Disease I: Introduction
375
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
375
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
730
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
730